The Discounted Cash Flow (DCF) valuation of Valerio Therapeutics SA (ALVIO.PA) is (3.25) EUR. With the latest stock price at 0.07 EUR, the upside of Valerio Therapeutics SA based on DCF is -4662.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 8.8% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.99) - (2.29) | (3.25) |
| Upside | -8507.2% - -3317.5% | -4662.1% |